KALA Share Price
NASDAQ: KALA | Micro Cap | Healthcare$3.31
+$3.31 (--%) Last updated on 19 Nov, 2026 | 01:59 ISTKALA Stock Performance
KALA Share Price Chart
$0.00$0.00
L
H
KALA Quarterly Profit & Loss
All figures in USD
KALA Annual Profit & Loss
All figures in USD
KALA Balance Sheet
All figures in USD Million
KALA Cash Flow
Annually
All figures in USD Million
Corporate Actions
About KALA
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
KALA Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $0.18 | $0.14 | -19.53% |
Oct 2026 | $0.43 | $0.17 | -60.51% |
Sep 2026 | $0.52 | $0.43 | -47.29% |
Aug 2026 | $0.76 | $0.81 | +3.18% |
Jul 2026 | $1.80 | $0.79 | -54.64% |
Jun 2026 | $2.29 | $1.74 | -22.20% |
May 2026 | $0.11 | $2.23 | +2,023.81% |
Apr 2026 | $0.19 | $0.10 | -39.66% |
Mar 2026 | $0.38 | $0.17 | -54.57% |
Feb 2026 | $0.52 | $0.38 | -26.49% |
Jan 2026 | $0.58 | $0.52 | -5.96% |
Dec 2025 | $1.29 | $0.55 | -41.93% |